Sumitomo Pharma Co Ltd (DNPUF:OTCMKTS)
$12.18 0.00 (0.00%)
Analysed Sumitomo Pharma Co Ltd (DNPUF:OTCMKTS) News Sources
Japan approves stem-cell treatment for Parkinson's in world first
The Economic Times on MSN
New muscarinic M4 receptor antagonists reported in Sumitomo Pharma patent
BioWorld
Japan OKs World's 1st iPS Cell-Based Products
Adnkronos
Japan OKs World's 1st iPS Cell Treatments
Adnkronos
Parkinson’s Breakthrough: Japan Approves World’s First Stem Cell Therapy
Times Now on MSN
Aurobindo arm launches Pomalidomide generic in US, adds to oncology line
Business Standard
Aurobindo Pharma launches Pomalidomide capsules in US market
Business Standard
Nifty Pharma SHARE PRICE
IndiaInfoline
Persistence Market Research Pvt. Ltd.: High Purity Alumina Market to Reach US$ 13,499.1 million by 2032 Expands Amid Electronics, EV, and LED Innovations - Persistence Market ...
FinanzNachrichten.de
Performance Shipping Inc. Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2025
FinanzNachrichten.de
What is the current price of Sumitomo Pharma Co Ltd (DNPUF:OTCMKTS)?
The current price of Sumitomo Pharma Co Ltd (DNPUF:OTCMKTS) is $12.18.
Sumitomo Pharma Co Ltd (DNPUF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of Sumitomo Pharma Co Ltd (DNPUF:OTCMKTS) since the previous trading day is $0.00.
Sumitomo Pharma Co Ltd (DNPUF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of Sumitomo Pharma Co Ltd (DNPUF:OTCMKTS) since the previous trading day is 0.00%.
What is This Week's average sentiment score for Sumitomo Pharma Co Ltd (DNPUF:OTCMKTS)?
This Week's average sentiment score for Sumitomo Pharma Co Ltd (DNPUF:OTCMKTS) is 67 out of 100.
What is This Week's average sentiment for Sumitomo Pharma Co Ltd (DNPUF:OTCMKTS)?
This Week's sentiment for Sumitomo Pharma Co Ltd (DNPUF:OTCMKTS) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.